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Bethesda, MarylandABSTRACT The amyloid precursor protein (APP) is subject to proteolytic processing by g-secretase within neuronal
membranes, leading to Alzheimer’s disease-associated b-amyloid peptide production by cleavage near the midpoint of
the single transmembrane (TM) segment of APP. Conformational properties of the TM segment may affect its susceptibility
to g-secretase cleavage, but these properties have not been established definitively, especially in bilayer membranes with phys-
iologically relevant lipid compositions. In this article, we report an investigation of the APP-TM conformation, using 13C chemical
shifts obtained with two-dimensional solid-state NMR spectroscopy as site-specific conformational probes. We find that
the APP-TM conformation is not a simple a-helix, particularly at 37C in multilamellar vesicles with compositions that mimic
the composition of neuronal cell membranes. Instead, we observe a mixture of helical and nonhelical conformations at the
N- and C-termini and in the vicinity of the g-cleavage site. Conformational plasticity of the TM segment of APP may be an
important factor in the g-secretase cleavage mechanism.INTRODUCTIONAlzheimer’s disease (AD) is the most common of the neuro-
degenerative diseases that cause dementia among elderly
people (1). One of the characteristic histopathological
markers of AD is the presence of proteinaceous deposits
(amyloid plaques) in the brain tissue and vasculature.
AD plaques contain amyloid fibrils formed by the 40- and
42-residue b-amyloid peptides (Ab40 and Ab42, respec-
tively), which are protease cleavage products of the amyloid
precursor protein (APP), a single-span transmembrane
(TM) protein of ~770 amino acids (see Fig. 1). Proteolytic
processing of APP occurs along two alternative pathways:
1), a nonamyloidogenic pathway in which sequential a-sec-
retase and g-secretase cleavages release the N-terminal
ectodomain of APP, a C-terminal intracellular APP domain
(AICD), and a peptide called p3; and 2), an amyloidogenic
pathway in which sequential b-secretase and g-secretase
cleavages release a somewhat shorter ectodomain, AICD,
and Ab peptides (2–4). Although both a-secretase and
b-secretase act outside the membrane surface, the g-secre-
tase complex cleaves the TM domain of APP within the
membrane, possibly through a sequential series of cleavages
that start on the C-terminal side of the final g-cleavage site
(5–9). The detailed mechanism by which g-secretase hydro-
lyzes the APP backbone in the TM bilayer environment is
not known (4,7). It is natural to wonder whether g-secretase
could cleave a TM segment that forms a stable a-helix, or
whether conformational variability in the TM segment
might play a role in APP processing, Ab production, and
variations in the C-terminal end of Ab.Submitted July 1, 2010, and accepted for publication December 8, 2010.
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0006-3495/11/02/0711/9 $2.00One distinctive feature of theAPP sequence is the presence
of several GXXXG and GXXXA motifs on the N-terminal
side of the g-cleavage site (see Fig. 1). Such motifs are
believed to promote helix-helix association in TM proteins
(10–12). Indeed, several reports indicate that APP or portions
of APP exist as dimers in micelles (13), simple phospholipid
bilayers (6,11), and biological membranes (14–16). Dimer-
ization has been reported both to increase (16) and to decrease
(14,15) Ab production. Certain APP mutations that are
associated with familial AD lie within the TM domain
(11,17–19). Although it has been suggested that a precise
helix-helix interaction interface is important for Ab produc-
tion (15), it remains unclear how a dimeric helical structure
would facilitate g-secretase activity and Ab production.
Lipid environment is an important factor in APP process-
ing and Ab production (20–23). Evidence exists that
abnormalities of lipid metabolism play a role in the develop-
ment of AD. Dietary ratios of unsaturated to saturated fatty
acids and u-3 to u-6 fatty acids are reported to affect the
risk of developing AD (24). The 34 variant of apolipoprotein
E (ApoE4) is known to be a risk factor for AD (25). Brain
lipids have distinctive compositions, rich in the cholesterol
and sphingolipids (26) that are also components of lipid
rafts (27). The enzyme complexes involved in APP process-
ing (a-, b-, and g-secretase) are all integral membrane
proteins, and both b-secretase and g-secretase are reported
to associate with cholesterol-rich lipid rafts in membranes
(20,28). In addition, Ab has been reported to reside in deter-
gent-insoluble glycolipid-enriched membrane compart-
ments, with possible implications for the initiation of fibril
formation (29). Moreover, it has been shown that Ab
production depends on lipid composition and cholesterol
levels, both in liposome-reconstituted systems (23) and in
cell cultures (21,30).doi: 10.1016/j.bpj.2010.12.3696
FIGURE 1 APP sequence, showing the TM and N-terminal juxtamem-
brane domains, with a-secretase, b-secretase, and g-secretase cleavage sites
indicated by arrows. Ab40 or Ab42 are produced by cleavage at the first or
second g-secretase cleavage sites. Asterisks indicate sites of mutations
within the TM domain that are associated with familial Alzheimer’s
disease. The APP-TM peptide studied in this work is underlined.
15N,13C-labeled amino acids were placed at the positions shown in bold
(A701 and V721 in APP-TM-AV; G709, V711, I712, A713, and T714 in
APP-TM-GVIAT).
712 Lu et al.In this article, we report a study of the conformation of
a peptide representing the TM segment of APP (residues
699–726, which we call APP-TM) in multilamellar vesicles
with various compositions. We use two-dimensional (2D)
solid-state NMR spectroscopy to probe the APP-TM confor-
mation site-specifically near the N- and C-terminal
membrane boundaries (A701 and V721) and around the
g-cleavage site (G709, V711, I712, A713, and T714). The
solid-state NMR data indicate that APP-TM is capable of
adopting a helical conformation, but that helical conforma-
tions coexist with nonhelical conformations at physiologi-
cally relevant temperatures and lipid compositions. The
conformational plasticity of APP-TM may have relevance
for APP processing and Ab production, for example, by
facilitating the exposure of peptide bonds for hydrolysis at
the g-cleavage site.MATERIALS AND METHODS
Sample preparation
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL),
except that L-a-phosphatidyl-L-serine (PS) was purchased from Sigma Al-
drich (St. Louis, MO). 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), and 1,
2-dioleoyl-sn-glycero-3-phospho-(10-rac-glycerol) (DOPG) are synthetic.
L-a-phosphatidylinositol-4-phosphate (PI), sphingomyelin (SM), total
cerebrosides, and total ganglioside extract are from porcine brain. Choles-
terol was from ovine wool and PS is from bovine brain. Brain total lipid
extract (BTLE) (Avanti Polar Lipids) contains 16.7% phosphatidylethanol-
amine, 10.6% PS, 9.6% phosphatidylcholine (PC), 2.8% phosphatidic acid,
1.6% phosphatidylinositol (PI), and 58.7% other components (weight
percentages). We also prepared a neuronal lipid mixture (NLM) by mixing
34.1% POPC, 20.0% DOPE, 3.5% SM, 3.5% cerebroside, 17.6% choles-
terol, 10.6% ganglioside, 3.5% PS, and 7.1% PI. This NLM composition
was chosen to mimic the composition of neuronal membranes reported
by Calderon et al. (26).
APP-TM peptides, corresponding to residues 699–726 of APP (see
Fig. 1), were synthesized at the 0.1-mmol scale on an Model 433A (Applied
Biosystems, Foster City, CA) automated peptide synthesizer using FMOC
chemistry and a FMOC-Lys(Boc)-Wang resin (0.47 mmol/g loading, Nova-
biochem, San Diego, CA). Samples were synthesized with uniformly
15N,13C-labeled amino acids at A701 and V721 (APP-TM-AV) or G709,
V711, I712, A713, and T714 (APP-TM-GVIAT). To improve yields,
APP-TM-AV was synthesized with pseudoproline dipeptides (obtained
from Novabiochem) at A713/T714 and I718/T719; APP-TM-GVIAT wasBiophysical Journal 100(3) 711–719synthesized with a pseudoproline dipeptide at I718/T719 and a dimethoxy-
benzyl derivative at G708. The native amino acid sequence was obtained
after standard cleavage protocols. After cleavage, the crude peptide was
recovered by evaporation of the cleavage solution under nitrogen gas, since
ether precipitation was ineffective. Peptides were purified by high-perfor-
mance liquid chromatography with a water/acetonitrile gradient containing
0.2% trifluoroacetic acid and a preparative C3 reverse-phase column. Purity
was confirmed by electrospray-ionization mass spectrometry.
Multilamellar vesicles (MLVs) containing APP-TM were prepared
by dissolving 2.5 mg of APP-TM in 1,1,1,3,3,3-hexafluoro-2-propanol,
then mixing thoroughly with 20 mg of lipids in chloroform or chloro-
form/methanol solvent. Organic solvents were removed under a stream of
dry nitrogen gas. The dried samples were left under vacuum overnight.
Water or buffer was added to the dry samples to produce a 40–60% hydra-
tion level (wt %). POPC MLVs were hydrated with water to the 60% level.
DOPG MLVs were hydrated with pH 6.0 phosphate buffered saline (PBS:
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4) to the
60% level. BTLE and NLM MLVs were hydrated with pH 6.0 PBS to the
40% level. The lower hydration level improved the cross-polarization (CP)
efficiency (i.e., 13C NMR signal strengths) in NMRmeasurements. Samples
were vortexed extensively and subjected to three freeze-thaw cycles to
ensure homogenization. Similar organic solvent comixing protocols have
been employed in previous studies and have proven to be a standard way
to reconstitute TM peptides into native secondary structures (31,32). The
hydrated samples were then transferred to 3.2-mm thin-wall magic-angle
spinning (MAS) rotors (36-ml sample volume) (Varian, Palo Alto, CA)
for the NMR measurements. Bilayer formation was confirmed with 31P
NMR spectra (see Fig. S1 of the Supporting Material).
For measurements of paramagnetic relaxation enhancements, BTLE
MLV samples were first partially dehydrated under vacuum, then rehy-
drated with 500 mM CuNa2-EDTA to a final Cu
2þ concentration of
120 mM. The initial hydration level was restored, as determined from the
sample mass, and samples were thoroughly mixed after addition of
CuNa2-EDTA.
APP-TM-AVsamples allowus toprobe theAPP-TMconformationnear the
N-terminal and C-terminal membrane boundaries, where previous studies
suggest the presence of nonhelical structures (33,34). APP-TM-GVIAT
samples allow us to probe the conformation around the g-cleavage site.Solid-state NMR measurements
NMR spectra were obtained on a Varian InfinityPlus spectrometer, oper-
ating at 1H and 13C NMR frequencies of 399.2 MHz and 100.4 MHz,
respectively. MAS frequencies were 9.0 kHz. For spectra recorded at
37C, the sample temperature was calibrated by observing the 1H NMR
frequency of water within the sample at the experimentally relevant MAS
frequency and 1H radio-frequency (rf) duty cycle (35). For low-temperature
spectra, the temperature was calibrated using a lead nitrate sample (36) with
the experimentally relevant MAS frequency and cooling gas flow rate.
13C rf field strengths were ~50 kHz for 1H-13C CP, with a 15% amplitude
ramp. CP contact times were typically 1.0–1.5 ms. 1H decoupling
fields were ~100 kHz. Two-dimensional 13C-13C NMR spectra were
obtained using rf-assisted diffusion (RAD) in the mixing period (37,38).
Two-dimensional 13C-13C NMR spectra were recorded with 100 t1 points
and a 27.6-ms increment. A two-dimensional 15N-13C NMR spectrum of
APP-TM-GVIAT in NLM MLVs was obtained at 55C using 15N-13C
CP in the mixing period, with a 1.5-ms contact time and 13C and 15N rf field
strengths of 49 kHz and 40 kHz, respectively, and with 60 t1 points and
a 115.2-ms increment. 31P NMR spectra without MAS were recorded
with a Hahn spin-echo pulse sequence, using a 200-ms echo period.
Two-dimensional NMR spectra were processed using NMRPipe (39).
13C chemical shift values are relative to tetramethylsilane, based on an
external reference of 1-13C-L-alanine powder at 177.95 ppm. The 15N
chemical shift reference frequency, representing liquid NH3 at 0.0 ppm,
was calculated from the 13C reference (40).
APP Transmembrane Domain Conformation 713Measurements of methyl 13C spin-lattice relaxation rates (R1) were per-
formed with a technique designed to suppress natural-abundance 13C NMR
signals from the phospholipids. As shown in Fig. S2, a frequency-selective
180 pulse at the NMR frequency of Ca sites (applied on alternate scans,
with alternating addition and subtraction of signals during signal averaging)
was followed by a 100 ms 13C-13C period with RAD irradiation for polar-
ization transfer to methyl sites. Spin-lattice relaxation was then allowed to
occur for a variable time tRelax before
13C NMR signals were digitized.
Measurements of motionally averaged 1Ha-
13Ca dipole-dipole couplings
were performed with the dipolar-shift (DIPSHIFT) correlation technique
shown in Fig. S5; this included a similar frequency-selective 180 pulse
and 100-ms RAD period, which allow 13Ca-
1Ha dipolar dephasing to be
detected through carbonyl and methyl 13C NMR signals without interfer-
ence from natural-abundance contributions from the phospholipids.RESULTS
APP-TM structure in single-component bilayers
APP-TM-AV was first reconstituted into POPC bilayers and
the two-dimensional 13C-13C NMR spectrum at room
temperature was recorded to probe the peptide conformation
(Fig. 2). 13C NMR chemical shifts can be used to distinguish
different secondary structures, as shown previously in
numerous solution and solid-state NMR studies (41–45).
In particular, a-helical secondary structure is indicated by
downfield shifts of 13CO and 13Ca signals and upfield shifts
of 13Cb signals, relative to reported random coil values (46).
The opposite trend indicates an extended, b-strand-like
backbone conformation. The spectrum in Fig. 2 shows
two Ca/Cb crosspeaks and two CO/Ca crosspeaks for
A701, corresponding to one set of helical chemical shifts
(Ca ¼ 52.0 ppm, Cb ¼ 17.0 ppm, and CO ¼ 176.3 ppm)
and one set of nonhelical chemical shifts (Ca ¼ 48.9 ppm,
Cb ¼ 20.6 ppm, and CO ¼ 173.1 ppm). For V721, only
one Ca-Cb crosspeak and one Ca-CO crosspeak are
detected, corresponding to nonhelical secondary structure
(Ca ¼ 58.3 ppm, Cb ¼ 33.0 ppm, and CO ¼ 171.9 ppm).
However, two V721 Cb-Cg crosspeaks are detected (Cb ¼
28.9 ppm, Cg ¼ 20.7 ppm, and Cb ¼ 33.0 ppm, Cg ¼
18.9 ppm). This result suggests the existence of a minorFIGURE 2 Two-dimensional 13C-13C NMR spectrum of APP-TM-AV
in POPC bilayers at 24C. Assignments of certain crosspeaks are shown,
with solid and open arrows indicating signals at nonhelical and helical
13C chemical shifts, respectively. One-dimensional slices at the dashed lines
are shown to the right, in the same order as in the two-dimensional spec-
trum. The RAD mixing period was 25 ms, and 320 scans were averaged
for each t1 point.a-helical component at the V721 position. Since A701 is
near the N-terminus of APP-TM and V721 is near the
C-terminus, the spectrum in Fig. 2 indicates that APP-TM
does not adopt a single, homogeneous structure in POPC
bilayers.
In previous studies, PG lipids have been used as one of the
membrane components for reconstitution of longer APP
fragments containing APP-TM (6,13). Therefore, we tested
reconsitution of APP-TM in DOPG bilayers. Furthermore,
APP processing is linked to a slightly acidic environment,
as Ab peptide production may occur in endosomes
(2,28,47), with pH 5.0–6.5. PBS with pH 6.0 was therefore
used to mimic the physiological environment.
Fig. 3 shows two-dimensional 13C-13C NMR spectra of
APP-TM-AV and APP-TM-GVIAT in DOPG bilayers at
room temperature. In Fig. 3 a, A701 shows a single set of
chemical shifts that agree well with the helical component in
POPC. V721 exhibits two sets of chemical shifts, with one
set corresponding to a helical structure (Ca ¼ 64.8 ppm,
Cb ¼ 29.8 ppm, Cg1 ¼ 21.1 ppm, Cg2 ¼ 19.8 ppm, and
CO¼ 176.3 ppm) and the other set corresponding to the non-
helical structure observed in POPC. Judging from the relative
intensities of helical and nonhelical signals, the population of
helical conformations at V721 in DOPG bilayers is increased
compared to that in POPC bilayers.
APP-TM-GVIAT has isotopic labels in the middle of the
APP-TM sequence, which is also the location of the g-sec-
retase cleavage site (see Fig. 1). The two-dimensional
13C-13C NMR spectra of APP-GVIAT (Fig. 3 b) shows
a single set of chemical shifts for all labeled residues, indi-
cating a predominant a-helical structure at the cleavage siteFIGURE 3 Two-dimensional 13C-13C NMR spectra of APP-TM-AV (a)
and APP-TM-GVIAT (b) in DOPG bilayers at 24C, with one-dimensional
slices at the dashed lines. The RAD mixing time was 100 ms, and 1024
scans were averaged for each t1 point. Solid arrows and hollow arrows indi-
cate nonhelical and helical 13C chemical shifts, respectively.
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714 Lu et al.in DOPG bilayers. This result is consistent with the pub-
lished work by Sato et al. (6) on a longer version of the
APP peptide, including both TM and juxtamembrane
domains.APP-TM structure in neuronal lipid bilayers
The membrane environment in the brain is quite different
from that in the single-component bilayers discussed above.
To examine the effects of a more realistic bilayer composi-
tion, we first examined APP-TM samples prepared with
brain total lipid extract, obtained from Avanti Polar Lipids
(see Materials and Methods). Both APP-TM-AV and
APP-TM-GVIAT samples showed a mixture of helical and
nonhelical conformations, judging from the chemical shifts,
with the relative intensities of the various signal components
being different at 24C and 37C (see Fig. S3 and Table 1).
Commercial BTLE contains >50% by weight of
unknown components. Cholesterol and sphingolipids have
been reported as important components in neuronal
membranes (26,48), although they are not included in theTABLE 1 NMR chemical shifts of APP-TM in bilayers with various
Residue Site POPC (24C) DOPG (24C)
A701 CO 176.35 0.7, 173.15 0.9 176.55 0.7 17
Ca 52.05 0.8, 48.95 1.1 52.35 0.8 5
Cb 17.05 0.6, 20.65 0.7 17.35 0.6 1
G709 CO 172.15 0.7 17
Ca 45.35 1.2 4
N
V711 CO 174.95 0.7 17
Ca 65.25 1.2 6
Cb 28.85 1.0 2
Cg1 20.95 0.7 2
Cg2 19.15 0.7 1
N
I712 CO 174.95 0.7
Ca 63.05 0.7 6
Cb 35.05 0.9 3
Cg1 27.65 0.7 2
Cg2 15.45 0.7 1
Cs1 11.05 0.6 1
N
A713 CO 176.05 0.9 17
Ca 53.55 0.9 5
Cb 16.15 0.6 1
N
T714 CO
Ca
Cb 65.65 1.2 6
Cg 19.25 0.7 1
N
V721 CO 171.95 0.9 176.35 0.7, 172.55 1.1 17
Ca 58.35 0.8 64.85 1.1, 58.25 1.0 6
Cb 28.95 1.0, 33.05 1.0 29.85 0.7, 32.95 1.0 2
Cg1 20.75 0.7, 18.95 0.8 21.15 0.7, 19.15 0.8 2
Cg2 19.25 0.7, 18.95 0.8 19.85 0.9, 19.15 0.8 1
13C shifts are relative to tetramethylsilane; 15N shifts are relative to liquid NH3.
Error limits represent half-widths at half-maxima of crosspeaks in the two-dim
Biophysical Journal 100(3) 711–719known components of the commercial BTLE. Therefore,
we prepared an artificial neuronal lipid mixture from
POPC, DOPE, SM, cerebroside, cholesterol, ganglioside,
PS, and PI, with proportions that mimic the reported compo-
sition of neuronal membranes (see Materials and Methods).
Fig. 4 shows two-dimensional 13C-13C NMR spectra of
APP-TM-AV and APP-TM-GVIAT in NLM MLVs at
37C. Although only signals at helical chemical shifts are
detected for A701, I712, and A713, signals at both helical
and nonhelical chemical shifts are detected for G709,
V711, T714, and V721. Compared with signals from the
POPC and DOPG samples, 13C NMR signals from the
NLM sample at 37C are relatively weak (approximately
half the signal strength per scan and per milligram of
peptide for the same labeled sites). Therefore, it is possible
that all labeled residues have both helical and nonhelical
components, but that the nonhelical signals for A701,
I712, and A713 are below the noise level in the two-dimen-
sional spectra. Signals from T714 are difficult to analyze
because the Ca/Cb crosspeaks are broad and close to the
diagonal. Nonetheless, comparison of Cb/Cg crosspeaks incompositions and temperatures
Brain lipid extract
(24C)
Neuronal lipid
mixture (37C)
Neuronal lipid
mixture (55C)
6.85 0.6, 173.75 1.0 177.05 0.5 177.45 0.7
2.85 1.5, 49.25 1.0 53.45 0.7 53.55 0.7
7.05 0.4, 20.95 1.2 17.15 0.4 16.85 0.7
2.85 0.5, 169.65 1.6 172.85 0.5, 169.15 0.6 172.95 0.7
5.55 1.7, 43.65 1.4 45.75 2.7, 43.85 1.5 45.65 1.5
107.35 1.0
3.05 0.5 175.75 0.8
5.25 1.5, 58.55 0.7 58.75 1.1 65.55 1.3
8.55 0.6, 32.75 1.3 28.85 1.5, 32.35 1.0 29.25 1.0
1.35 0.8, 19.45 0.7 21.55 0.6, 19.65 0.6 21.15 1.0
9.65 0.7, 19.45 0.7 19.85 0.6 20.15 1.0
123.05 1.2
175.35 0.4 175.65 0.8
3.25 0.7 64.15 1.4
5.45 1.2 35.75 1.3 35.85 1.1
7.95 1.2 28.05 1.6 27.95 1.6
5.95 0.4 15.95 0.4 15.65 1.0
1.35 0.5 11.35 0.4 12.05 0.7
118.75 1.1
5.75 1.2 176.35 0.5 176.35 0.7
3.65 1.2 53.85 1.1 53.55 0.8
6.65 0.6 16.55 0.5 16.65 1.0
119.45 0.8
5.95 1.7 66.55 1.6, 69.65 1.6 66.35 0.5
9.65 0.7 19.75 0.6 19.85 1.0
114.15 1.2
6.75 0.6, 172.95 1.0 176.45 0.8, 172.85 0.6 176.65 0.7
4.75 0.8, 58.65 0.8 64.25 1.5, 59.05 0.7 64.75 0.7
9.65 1.0, 32.65 0.6 29.45 1.0, 33.25 0.7 29.45 1.0
0.75 1.2, 19.35 0.6 19.35 0.4 21.05 1.2
9.45 0.6, 19.35 0.6 20.05 0.4, 19.35 0.4 20.05 1.2
13C chemical shifts that indicate nonhelical conformations are underlined.
ensional 13C-13C NMR spectra.
FIGURE 4 Same as Fig. 3, but using a neuronal lipid mixture at 37C
instead of DOPG at 24C. Each t1 point represents an average over 2048
scans.
APP Transmembrane Domain Conformation 715Figs. 3 b and 4 b indicates the presence of two signal compo-
nents for T714 in NLM MLVs.
Two-dimensional 13C-13C NMR spectra of APP-TM-
GVIAT in NLM and BTLE at 37C are similar in that
both spectra show only nonhelical signals for V711 and
mixtures of helical and nonhelical signals for T714 (Fig. 4
b and Fig. S3 c). Predominant conformations at I712 are
apparently different and A713 signals are absent from the
BTLE spectrum.
Fig. 5 shows two-dimensional 13C-13C NMR spectra of
APP-TM-AV and APP-TM-GVIAT in NLM MLVs at
55C. At the lower temperature, 13C NMR signals areFIGURE 5 Same as Fig. 4, but at55C instead of 37C. The RADmix-
ing time was 25 ms. Each t1 point represents an average over 416 scans.stronger (by a factor of 5 compared to those at 37C), and all
labeled residues show a single set of crosspeaks at chemical
shifts that are consistent with a purely helical conformation.
The only possible exception is T714, which may show
a minor Cb/Cg crosspeak component with a nonhelical
13Cb chemical shift. A two-dimensional
15N-13C NMR
spectrum of APP-TM-GVIAT in the neuronal lipid mixture
was also obtained at 55C (see Fig. S3). A single set of
intraresidue 15N/13Ca crosspeaks was observed in this spec-
trum. Thus, it appears that APP-TM undergoes a change
from a state with at least two conformations in the neuronal
lipid mixture to a state with a single, helical conformation as
the sample temperature decreases from the physiologically
relevant 37C to 55C.Dynamics of APP-TM
As described above, 13C NMR signals from APP-TM in
NLM MLVs at 37C were weaker than signals in POPC
and DOPG at 24C. The weaker signals may result from
molecular motions that attenuate 1H-13C dipole-dipole
couplings (thereby decreasing the build-up rate of
13C spin polarization during the 1H-13C CP period in
a one-dimensional or two-dimensional measurement) and
13C-13C dipole-dipole couplings (thereby decreasing the
build-up rate of crosspeak signals during the mixing period
in two-dimensional measurements). Motions on the micro-
second–millisecond timescale would also result in short
rotating-frame spin-lattice relaxation times (T1r) for
1H
and 13C nuclei, which would reduce the CP efficiency, and
short 13C transverse relaxation times (T2), which would
further reduce the build-up rate of crosspeak signals. Such
slow motions may include exchange between the helical
and nonhelical conformations discussed above.
As a simple probe of molecular motions, we recorded
one-dimensional 13C NMR spectra of APP-TM-AV and
APP-TM-GVIAT in NLM MLVs as a function of the
1H-13C CP contact time, at both 37C and 70C. Fig. 6
shows the dependence of resolvable signal intensities (i.e.,
peak areas) on the contact time. Signals from A701 and
A713 Ca sites could be resolved in the one-dimensional
spectra, and total signals from CO sites of labeled residues
could also be measured. Other peptide signals were not
resolved from natural-abundance lipid signals and hence
could not be quantified. Signals were fit with the equation
SðtÞ ¼ S0ð1 et=t1Þet=t2 , where t is the CP contact
time, t1 is the characteristic build-up time (which reflects
the strength of 1H-13C dipole-dipole couplings), and t2 is
the decay time due to T1r processes (which reflect slow
motions). Best-fit parameters are reported in Table S1.
As shown in Fig. 6 a, the A701 Ca signal builds up
more slowly at 37C (t1 z 0.38 ms) than at 70C
(t1z 0.12 ms), indicating the presence of rapid molecular
motions that attenuate 1H-13C dipole-dipole couplings at
37C. The value of t2 increases somewhat at the lowerBiophysical Journal 100(3) 711–719
FIGURE 6 Dependence of 13C signal intensities in one-dimensional
13C NMR spectra on the 1H-13C cross-polarization contact time. Data are
shown for the Ca signals of A701 and A713 (a and b) and the total peptide
carbonyl signals of APP-TM-AVand APP-TM-GVIAT (c and d). Solid lines
are fitted as described in the text and Table S1. Samples were in the
neuronal lipid mixture. Open triangles and dashed lines in c represent lipid
carbonyl signals at 37C.
716 Lu et al.temperature (t2 z 5.2 ms vs. t2 z 3.7 ms). As shown in
Fig. 6 b, the initial build-up of the A713 Ca signal is nearly
the same at 37C and 70C (t1z 0.12 ms), but the subse-
quent decay is significantly more rapid at 37C (t2z 4.0 ms
vs. t2 z 8.9 ms). This result suggests the presence of
temperature-dependent slow motions at the g-secretase
cleavage site. Data for CO sites show similar trends,
although they are less pronounced. The build-up of
combined CO signals for A701 and V721 is somewhat
slower at 37C than at 70C (Fig. 6 c), and the decay of
combined CO signals for G709, V711, I712, A713, andBiophysical Journal 100(3) 711–719T714 is somewhat more rapid at 37C than at 70C
(Fig. 6 d).
Data in Fig. 6 could in principle be sensitive to both local
conformational dynamics and overall molecular rotational
diffusion in the bilayer (49). The fact that the CP build-up
time for A713 Ca is nearly independent of temperature
suggests that rotational diffusion of APP-TM in NLM
MLVs at 37C is quite slow (millisecond or longer
timescale), as observed by Luo et al. in NMR studies of
TM peptides in bilayers with similar compositions (50).
Additional information about the APP-TM conformation
and dynamics was obtained from measurements of motion-
ally averaged 1Ha-
13Ca dipole-dipole couplings, shown in
Fig. S5 for APP-TM-GVIAT in BTLE MLVs at 37C.
Coupling strengths (averaged over the labeled residues,
since signals for individual residues were not resolved)
were found to be 175 1 kHz from a comparison of exper-
imental DIPSHIFT data (detected through carbonyl and
methyl 13C NMR signals after suppression of natural-abun-
dance contributions from the phospholipids as shown in
Fig. S2 and Fig. S5). This value is significantly smaller
than the unaveraged coupling strength of 23 kHz observed
in similar measurements on rigid model compounds
(50,51), but significantly larger than motionally averaged
couplings typically observed for TM helical peptides due
to rotational diffusion about the bilayer normal. For
example, motionally averaged 1Ha-
13Ca dipole-dipole
couplings for the TM segment of HIV-1 Vpu are in the 3–
8 kHz range (51). Together with the 13C chemical shifts dis-
cussed above, the observed couplings for APP-TM-GVIAT
argue against a stable TM helix for APP-TM at physiologi-
cally relevant temperatures. It is interesting to note that the
DIPSHIFT data in Fig. S5 show a nearly complete recovery
of the signal intensity when the Lee-Goldburg dephasing
time, tLG, equals 2tR. This observation indicates that
motional averaging occurs on a timescale around 1 ms or
less in BTLE MLVs at 37C (52). The apparent absence
of rapid motional averaging in NLM MLVs at 37C is
attributable to their higher SM and cholesterol concentra-
tions (50).
The absence of a stable helical conformation for APP-TM
in BTLE and NLM MLVs at physiologically relevant
temperatures raises the possibility that the APP-TM peptide
may lie on the bilayer surface under these conditions, rather
than being inserted in the bilayer. Evidence for insertion is
provided by the spin-lattice relaxation data in Fig. S6. R1
relaxation rates for 13C-labeled sites are 0.9 s1 in BTLE
MLVs at 37C in the absence of paramagnetic species, for
both APP-TM-AV and APP-TM-GVIAT. Addition of
120 mM CuNa2-EDTA has no effect on the R1 value for
APP-TM-GVIAT, but increases the R1 value for APP-TM-
AV to 1.6 s1. This result is consistent with exposure of
A701 and V721, near the N- and C-termini of APP-TM,
to paramagnetic relaxation by Cu2þ and sequestration of
residues 709–714 within the bilayer.
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The solid-state NMR data described above clearly indicate
that the membrane environment plays a significant role in
modulating the APP-TM structure. In DOPG MLVs at
24C, signals that indicate helical conformations are
observed both at the N- and C-termini (A701 and V721)
and at the g-secretase cleavage site (G709, V711, I712,
A713, and T714). Nonhelical signals are also observed at
the C-terminus. In POPC MLVs at 24C, both helical and
nonhelical signals are observed at both the N-terminus and
the C-terminus. In the neuronal lipid mixture, only helical
signals are observed at 55C, but both helical and nonhel-
ical signals are observed at G709, V711, T714, and V721 at
the physiological temperature of 37C. Because signals at
the higher temperature are relatively weak, presumably
due to molecular motions and conformational exchange in
the more fluid lipid environment, we cannot rule out the
presence of nonhelical conformations at A701, I712, and
A713 as well, even though nonhelical signals are not de-
tected above the noise level in the NMR spectra. In vesicles
formed from the commercial brain total lipid extract, A701,
G709, V711, and V721 show both helical and nonhelical
signal components at 24C. The overall conclusion from
these measurements is therefore that APP-TM does not
adopt a stable, homogeneous helical conformation in bila-
yers with physiologically relevant lipid compositions at
physiologically relevant temperatures. Helical conforma-
tions coexist with nonhelical conformations.
Although we do not have a direct measurement of the
timescale for exchange between helical and nonhelical
conformations, this timescale must exceed 1 ms in the
neuronal lipid mixture at 37C. More rapid conformational
exchange would produce solid-state NMR spectra with
a single set of 13C chemical shifts at the intermediate,
time-averaged values.
The observation of nonhelical conformations around the
g-secretase cleavage site may have important implications
for the mechanism of cleavage and hence for Ab production.
Previous studies of longer APP constructs by solution
NMR (13) and solid-state NMR (6) have found that the
TM segment of APP forms a helix in LMPG micelles at
45C and in dimyristoylphosphatidylcholine/dimyristoyl-
phosphatidylglycerol vesicles at 68C. Moreover, the
helical conformation exists as a dimer (or possibly a higher
oligomer), as indicated by glutaraldehyde cross-linking
in LMPG micelles (13) and by direct measurements
of intermolecular 13C-13C dipole-dipole couplings in dimyr-
istoylphosphatidylcholine/dimyristoylphosphatidylglycerol
vesicles (6). In addition, Gorman et al. have used fluores-
cence resonant energy transfer to show that APPTMpeptides
form dimers in DOPG vesicles (11). Dimerization of the TM
segment is generally believed to be a consequence of inter-
molecular interactions between GXXXG motifs in residues
696–718 (see Fig. 1) (6,10–12). These previous findingsare consistent with the solid-state NMR data described
above, which show that APP-TM forms a stable helix both
in DOPG vesicles at 24C and in vesicles with more complex
lipid compositions at low temperatures.
On the other hand, there is considerable evidence in the
literature that complex lipid compositions are required for
normal g-secretase activity (21,23,28,30,48) and that the
helical conformation and dimerization of the TM segment
may be (at least partially) disrupted under physiological
conditions (14,33,34). In experiments on site-directed
cysteine mutants of the 99-residue polypeptide C99 (running
from the APP C-terminal domain to the b-secretase cleavage
site) inmicrosomalmembranes, Grziwa et al. found that only
residues 708–719 were protected from cysteine labeling
(33). In a similar way, aspartate scanning mutagenesis
experiments by Tischer et al. suggested that the C-terminal
side of the TM boundary was at residue 718 (34). These
experiments contradict simple expectations if the entire
hydrophobic segment betweenK699 andK724were a stable,
continuous helix. Osenkowski et al. report that g-secretase
activity, monitored by Ab40 and Ab42 production in a lipo-
some-reconstituted system, depends strongly on lipid
composition, especially the presence of non-PC lipids and
cholesterol (23). In cell cultures, Ehehalt et al. found that
reductions in membrane cholesterol led to reduced Ab
production (30). In a similar way, Hartmann et al. found
that inhibition of cholesterol biosynthesis in neuronal cell
cultures reduced the production of Ab40 and Ab42 (21).
Also in cell cultures, Eggert et al. found that dimerization
of an APP fusion protein (through interactions of the
C-terminal fusion partner) reduced the total Ab production
(14). One possible interpretation of these findings is that
the conformation of the APP TM segment is affected by lipid
composition and cholesterol content, and that the nonhelical
conformations observed in our solid-state NMR spectra of
APP-TM in realistic lipid environments are the conforma-
tions that are susceptible to g-secretase cleavage. In the non-
helical state, the TM segment may not dimerize, especially
if helical GXXXG motifs are required for dimer formation.
Other interpretations of the experiments of Osenkowski
et al. (23), Ehehalt et al. (30), Hartmann et al. (21), and Eggert
et al. (14) are certainly possible, since lipid composition may
also directly affect various properties of the b-secretase and
g-secretase complexes (e.g., structure, enzymatic activity, or
localization) and since APP dimerization and lipid depen-
dence may also affect susceptibility to a- and b-secretase
cleavage (16,20,22). Nonetheless, the conformational prop-
erties of the APP TM segment are likely to play an important
role, in addition to these other factors.
Beel et al. found that solution NMR signals from the TM
segment of C99 became weak when a cholesterol analog
was added to their LMPG micelles (13). Beel et al. attrib-
uted this observation to an increase in the micelle orienta-
tional correlation time, but conformational exchange
within the TM segment would also reduce the solutionBiophysical Journal 100(3) 711–719
718 Lu et al.NMR signal intensities. Beel and Sanders have also sug-
gested that TM helix destabilization may be important for
presinilin-mediated proteolysis, based on their estimates of
helix-forming propensities at the cleavage site of varioius
presinilin substrates (7).
Scheuermann et al. found that cysteine-linked dimerization
ofAPP increasedAb production in cell cultures, but dimeriza-
tion in these experimentswas on theN-terminal side of theTM
segment and may have affected a-secretase and b-secretase
activity, rather than g-secretase activity (16). Kienlen-Cam-
pard et al. found that certain glycine-to-leucine substitutions
in GXXXG motifs (including G704L, using our numbering
of the APP sequence) reduced Ab production in cell cultures
but actually promoted dimerization and did not inhibit the
release of the APP intracellular C-terminal domain by g-sec-
retase cleavage after L720 (15), called the 3-cleavage site
(5–9). More detailed studies of the conformational effects of
substitutions in theGXXXGmotifswould be needed to clarify
the relation between our solid-state NMR data for APP-TM
and the experiments of Kienlen-Campard et al.
Vetrivel et al. have presented evidence that the g-secretase
complex resides in cholesterol-rich lipid rafts in neuronal and
nonneuronal cell membranes (28). Kalvodova et al. have pre-
sented evidence that b-secretase also resides preferentially in
raftlike membrane domains (20). Modulation of a-, b-, and
g-secretase cleavages by changes in cholesterol levels that
affect localization has been suggested to be part of a mecha-
nism by which APP participates in regulation of cholesterol
biosynthesis (13,21,25). Our own data do not provide direct
evidence for or against APP-TM localization to rafts, but it
is clear that lipid composition plays a critical role in APP
processing and Ab production. Therefore, we believe that
the dependence of APP-TM conformation on lipid environ-
ment revealed by our data should be considered in the design
and interpretation of future structural and biochemical
studies of the APP/g-secretase system.
Finally, we note that Miyashita et al. have recently
reported computational studies of APP, including residues
672–726 in monomeric form and residues 694–726 in
dimeric form, using replica-exchange molecular dynamics
and an implicit bilayer model (53,54). They find that
the APP694–726 dimer has a low helix population on the
N-terminal side of the g-cleavage site, whereas APP672–726
is primarily (>80%) helical from I702 to L723, with a fluctu-
ating bend or kink at G708/G709. These distortions from an
ideal TM a-helix may be related to the nonhelical conforma-
tions observed in our solid-state NMR measurements. Since
our data indicate that lipid composition plays amajor role, an
implicit bilayer model may not be sufficient to replicate the
experimental observations entirely.SUPPORTING MATERIAL
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